PIPages
Labs

Omeid Heidari

University of Washington, WA·Public Health & Epidemiology·Early-career

People who use opioids face high risks of overdose and of HIV infection or poor HIV outcomes. Medications such as buprenorphine reduce overdose, drug use and infections, and can help people stay engaged with HIV prevention and treatment.

Fields

Public Health & Epidemiology

Medicine & Clinical Research

Topics

opioid use disorder

buprenorphine

HIV prevention

Grants
1 known grant, through May 2029

What they work on

  1. Design the Community-Based Opioid Treatment (CBOT) strategy and its implementation plan through interviews with patients, providers, nurses and other stakeholders, then pilot and refine it with 10 participants over three months.
  2. Compare the feasibility, acceptability and sustainability of CBOT, delivered by nurse care managers and outreach workers, with clinic-based opioid treatment in a randomized type-3 hybrid trial of 140 people who use opioids.
  3. Assess whether CBOT improves retention on buprenorphine, a medication for opioid use disorder, and HIV care outcomes such as viral load suppression or HIV testing uptake.
  4. Estimate the costs of delivering CBOT using continuously collected micro-costing data.

More about the research

Yet many patients drop out of care, and keeping them in treatment for a full year remains difficult even with good clinic-based programs. This project asks whether bringing care directly to people in their communities can keep them in treatment longer.

Why it matters

People who use opioids often fall out of addiction and HIV care, raising their risk of overdose and HIV. If nurse-led community delivery of buprenorphine and HIV services proves feasible, acceptable and affordable, clinics and health systems could adopt it to keep these high-risk patients in care longer, with potential benefits for overdose prevention and HIV viral suppression.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Community-Based Opioid Treatment (CBOT): Development and testing of a novel nurse-led model to deliver opioid use disorder treatment and HIV prevention and care in the community setting.

NIH · Jun 2025 – May 2029

Closest labs

Hansel Tookes

University of Miami, FL·Public Health & Epidemiology

Determine whether the Comprehensive-TeleHealth-concieRge model increases engagement in HIV prevention compared with offsite referral plus peer navigation, in a randomized trial of 350 people who inject drugs recruited at a low barrier clinic in Miami.

Michael Stein

Boston University, MA·Medicine & Clinical Research

Test whether Behavioral Activation, Attendance Reinforcement and Peer Motivational Interviewing improve six-month buprenorphine retention, using a factorial randomized trial of 240 patients in office-based addiction care.

Beth Meyerson

University of Arizona, AZ·Public Health & Epidemiology

Adapt the four MPACT components (staff trauma-informed training, trauma navigation, clinic self-assessment and reflective supervision) for opioid treatment programs through a participatory planning process with providers, patients and people with lived drug use experience.

The school

University of Washington: 81 labs on PI Pages, $1.7B a year on research, 694 research doctorates a year.

More about University of Washington

Reach out

A start for your email. Fill in the brackets.